Skip to nav Skip to content

The largest transplant practice of its kind in the southeastern United States, Moffitt Cancer Center’s Blood and Marrow Transplant and Cellular Immunotherapy (BMT CI) Program provides patients with comprehensive diagnostic, donor matching, transplant as well as chimeric antigen receptor or CAR T cell therapy, other immunotherapy, and supportive care services in a single location.

hospital team for blood and bone marrow transplant

Our BMT and cellular immunotherapy specialists cater to patients with leukemia, multiple myeloma, lymphoma, aplastic anemia, myelodysplastic syndrome (MDS), myelofibrosis, sickle cell anemia and certain solid tumors such as germ cell tumor. Moffitt’s patients benefit from the expertise of physicians who focus exclusively on the treatment of hematological conditions with transplant and CAR T, and collaborate to develop individualized treatment plans. It is this level of attention – combined with our advanced treatments and compassionate care – that leads to better outcomes and improved quality of life for our patients.

A key distinguishing factor of Moffitt’s BMT CI program is the talented physicians who make up our team. Here, experienced medical oncologists, hematologists, pathologists, psychologists and other specialists such as social workers provide a full spectrum of treatment and supportive care to our patients. 

BMT information for referring physicians

There are several reasons why physicians throughout the nation refer patients to Moffitt’s Blood and Marrow Transplant and Cellular Immunotherapy Program (BMT CI). For example, Moffitt is: 

  • A National Marrow Donor Program (NMDP) transplant and collection center
  • Fully accredited by the Foundation for the Accreditation of Cellular Therapy (FACT)
  • Among a select few providers to offer bone marrow transplantation (BMT) to adults ages 70 and older
  • One of only a handful of centers in the nation performing a high volume of transplants with outcomes exceeding expected survival 
  • A core member of the BMT Clinical Trials Network (BMT CTN) that spearheads an ambitious clinical trials program through which our patients can receive the latest treatment breakthroughs
  • A center performing transplants from various donor types including related haploidentical and mismatched unrelated donors
  • A center specialized in the treatment of patients with severe and refractory graft-versus-host disease (GVHD)
  • A center conducting a high volume of CAR T cell therapy for lymphoma, myeloma and leukemia under the dedicated Immune Cell Therapy (ICE-T) service, and has led many pivotal national clinical trials for CAR T cell therapy
  • A center with a dedicated survivorship program for BMT and CAR T recipients

To refer a patient to Moffitt’s BMT and cellular immunotherapy specialists, complete our online form or contact a physician liaison. We place emphasis on minimizing referral times and aim to respond to all referrals on the same business day that they are received.

Medically reviewed by Taiga Nishihori, MD

  • BMT and CI Leadership
    Frederick  Locke, MD
    Department Chair, Blood and Marrow Transplant and Cellular Immunotherapy
    Program Lead, Blood and Marrow Transplant and Cellular Immunotherapy

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Title

    Program Co-Leader, Immuno-Oncology; Chair, Department of Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Nelli  Bejanyan, MD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Title

    Program Leader, Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

  • Blood and Marrow Transplant & Cellular Immunotherapy at Magnolia Campus

    Meet the providers located in Tampa, FL. 

    Melissa  Alsina, MD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Cancer Focus

    Leukemia, Multiple Myeloma-Plasma Cell Tumor

    4.9 (207)
    Claudio  Anasetti, MD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Cancer Focus

    Leukemia, Multiple Myeloma-Plasma Cell Tumor, Myelodysplastic Syndromes (MDS)

    Nelli  Bejanyan, MD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Title

    Program Leader, Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Cancer Focus

    Leukemia, MDS, Myelodysplastic Syndromes (MDS)

    Kaaron  Benson, MD

    Program

    Pathology

    Specialty

    Pathology

    Cancer Focus

    Hodgkin Lymphoma, Leukemia, MDS, Multiple Myeloma-Plasma Cell Tumor, Myelodysplastic Syndromes (MDS), Non-Hodgkin Lymphoma

    Margaret  Booth-Jones, PhD

    Program

    Supportive Care Medicine

    Specialty

    Clinical Psychology

    4.9 (152)
    Omar  Castaneda Puglianini, MD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Medical Oncology

    Cancer Focus

    Multiple Myeloma-Plasma Cell Tumor

    5 (45)
    Hany  Elmariah, MD, MS

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Cancer Focus

    Leukemia, MDS, Myelodysplastic Syndromes (MDS)

    4.9 (51)
    Rawan  Faramand, MD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Cancer Focus

    Leukemia, MDS, Myelodysplastic Syndromes (MDS)

    4.9 (40)
    Ciara  Freeman, MD, PhD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Medical Oncology

    4.9 (35)
    Doris  Hansen, MD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Cancer Focus

    Hodgkin Lymphoma, Leukemia, Multiple Myeloma-Plasma Cell Tumor, Non-Hodgkin Lymphoma

    5 (18)
    Michael  Jain, MD, PhD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    4.9 (28)
    Farhad  Khimani, MD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Cancer Focus

    Hodgkin Lymphoma, Leukemia, Myelodysplastic Syndromes (MDS), Non-Hodgkin Lymphoma

    4.9 (31)
    Aleksandr  Lazaryan, MD, MPH, PhD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Cancer Focus

    Cutaneous Lymphoma (CTCL), Hodgkin Lymphoma, Non-Hodgkin Lymphoma

    4.9 (33)
    Hien  Liu, MD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Cancer Focus

    Cutaneous Lymphoma (CTCL), Hodgkin Lymphoma, Non-Hodgkin Lymphoma

    4.9 (35)
    Frederick  Locke, MD
    Department Chair, Blood and Marrow Transplant and Cellular Immunotherapy
    Program Lead, Blood and Marrow Transplant and Cellular Immunotherapy

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Title

    Program Co-Leader, Immuno-Oncology; Chair, Department of Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Cancer Focus

    Hodgkin Lymphoma, Leukemia, Multiple Myeloma-Plasma Cell Tumor, Non-Hodgkin Lymphoma

    Sayeef  Mirza, MD, MPH

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Hematology/Oncology

    Cancer Focus

    Hodgkin Lymphoma, Leukemia, Myelodysplastic Syndromes (MDS), Non-Hodgkin Lymphoma

    Asmita  Mishra, MD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Cancer Focus

    Leukemia, MDS, Myelodysplastic Syndromes (MDS)

    Michael  Nieder, MD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Taiga  Nishihori, MD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Cancer Focus

    Cutaneous Lymphoma (CTCL), Hodgkin Lymphoma, Leukemia, MDS, Multiple Myeloma-Plasma Cell Tumor, Myelodysplastic Syndromes (MDS), Non-Hodgkin Lymphoma, Testicular Cancer

    4.9 (40)
    Jose  Ochoa-Bayona, MD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Cancer Focus

    Leukemia, Multiple Myeloma-Plasma Cell Tumor, Ovarian Cancer, Testicular Cancer

    4.9 (33)
    Lia  Perez, MD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Cancer Focus

    Hodgkin Lymphoma, Leukemia, MDS, Myelodysplastic Syndromes (MDS), Non-Hodgkin Lymphoma

    Fabiana  Perna, MD, PhD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Hematology

    Cancer Focus

    Hodgkin Lymphoma, Leukemia, MDS, Multiple Myeloma-Plasma Cell Tumor, Myelodysplastic Syndromes (MDS), Non-Hodgkin Lymphoma

    Joseph  Pidala, MD, PhD

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Cancer Focus

    Leukemia, MDS, Myelodysplastic Syndromes (MDS)

    Ramon  Sandin, MD, MS

    Program

    Pathology

    Specialty

    Pathology

    Cancer Focus

    Hodgkin Lymphoma, Leukemia, MDS, Multiple Myeloma-Plasma Cell Tumor, Myelodysplastic Syndromes (MDS), Non-Hodgkin Lymphoma

    Karla  Adams, PA-C

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Danielle  Baratta, PA-C

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Blood and Marrow Transplant and Cellular Immunotherapy

    Chrissy  Copponex, APRN

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Marian  Dam, APRN

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    KC  Garfield, APRN

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    William  Giove, PA

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Kristy  Harvey, PA-C

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Erik  Hollers, PA-C

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Nikita  Hope, APRN

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Meredith  Keppel, PA-C

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Jessica  Marin, PA-C

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Hematology/Oncology

    Cancer Focus

    Leukemia, Multiple Myeloma-Plasma Cell Tumor, Non-Hodgkin Lymphoma

    Catherine  Quealy, APRN

    Program

    Blood and Marrow Transplant and Cellular Immunotherapy

    Specialty

    Hematology/Oncology

    Cancer Focus

    Hodgkin Lymphoma, Leukemia, Multiple Myeloma-Plasma Cell Tumor, Myelodysplastic Syndromes (MDS), Non-Hodgkin Lymphoma

  • Bone and Marrow Transplant & Cellular Immunotherapy at Memorial Health

    Meet the providers located in Pembroke Pines, FL.

    Yehuda  Deutsch, MD

    Program

    Malignant Hematology and Cellular Therapy at Memorial Healthcare System

    Specialty

    Hematology/Oncology

    Cancer Focus

    Hodgkin Lymphoma, Leukemia, MDS, Multiple Myeloma-Plasma Cell Tumor, Myelodysplastic Syndromes (MDS), Non-Hodgkin Lymphoma

    Hugo  Fernandez, MD
    Department Chair, Malignant Hematology and Cellular Therapy at Memorial Healthcare System
    Program Lead, Malignant Hematology and Cellular Therapy at Memorial Healthcare System

    Program

    Malignant Hematology and Cellular Therapy at Memorial Healthcare System

    Title

    Chair, Malignant Hematology and Cellular Therapy at Memorial Healthcare System

    Specialty

    Medical Oncology

    Cancer Focus

    Leukemia, Myelodysplastic Syndromes (MDS)

    Jose  Sandoval Sus, MD

    Program

    Malignant Hematology and Cellular Therapy at Memorial Healthcare System

    Specialty

    Hematology/Oncology

    Cancer Focus

    Hodgkin Lymphoma, Leukemia, MDS, Multiple Myeloma-Plasma Cell Tumor, Myelodysplastic Syndromes (MDS), Non-Hodgkin Lymphoma